144 results
424B5
ENVB
Enveric Biosciences Inc
3 May 24
Prospectus supplement for primary offering
5:05pm
or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default … by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise
8-K
EX-99.1
ENVB
Enveric Biosciences Inc
19 Mar 24
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive
7:00am
joint pathology applications, the undisclosed licensee would assume responsibility for all future product development efforts and in return would
424B5
ajsi77 09n39
11 Mar 24
Prospectus supplement for primary offering
12:35pm
8-K
EX-99.1
nq3n74t17jlitmyb1yf
29 Feb 24
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
7:00am
8-K
EX-10.1
er6ehq5q0fvla 4q1
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
424B5
0ar5nqsv
1 Sep 23
Prospectus supplement for primary offering
5:28pm
8-K
EX-1.1
3lae5jh0nsi8srpnhzc
1 Sep 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-10.2
y1ora0vd
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-10.1
5cui027g1k1n216q
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
424B5
bbmhbh2x2
26 Jul 22
Prospectus supplement for primary offering
8:35am
8-K
EX-10.1
n0s8qvwjsa7vg
11 May 22
Enveric Biosciences Announces Plans to Spin-off and Dividend its Cannabinoid Pipeline to Shareholders
1:46pm